FDA Inspection
VICTOGEN PHARMAVICTOGEN PHARMA – FDA Inspection, Sep 25, 2026
Record Details
This FDA Inspection record concerns VICTOGEN PHARMA, with an inspection on September 25, 2026, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · ccf150df-fd38-450f-816e-5bbb50aa773f
Inspection Facts
- Inspection number
- 1337482
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.166(a)Results not used for expiration dates, storage cond.
- 21 CFR 211.22(a)Lack of quality control unit
- 21 CFR 211.67(b)(4)Cleaning SOPs/equipment identification
- 21 CFR 211.84(d)(2)Establish reliability of supplier's C of A
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.